Ribo expands beyond the liver with RiboPepSTAR™ – enabling targeted siRNA delivery to multiple organs
SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. (“Ribo” or “the Company”, Hong Kong Stock Exchange code: 6938) had been invited to give a
